-
New Comprehensive Clinical Guidance on VTE Treatment
-
Thrombophilia – Information Handout for Patients
Stephan Moll, MD writes… An information article on various aspects of thrombophilia, written for patients and family members, was published today – available here – as a Vascular Disease Patient Information Page in the journal Vascular Medicine. It addresses (a) in which patient with venous thromboembolism to consider thrombophilia testing, (b) what tests might be appropriate to do, (c) how the test results…
-
Three Things We Shouldn’t Do
-
International Coagulation Meeting (ISTH 2013): Highlights
Stephan Moll, MD writes… A major international coagulation conference, the bi-annual meeting of the International Society for Thrombosis and Haemostasis (ISTH; http://www.isth.org), took place in Amsterdam, Holland, from June 29th to July 4th, 2013. The clinically relevant highlights about thrombosis and anticoagulation are summarized below.
-
Thrombophilia Testing – Reliable on Anticoagulants?
Stephan Moll, MD writes… The decision how long to treat a patient with venous thromboembolism (VTE) with anticoagulants can often be made based on the patient’s history alone, i.e. the circumstances of the VTE event (provoked versus unprovoked). Often, no thrombophilia testing is needed. However, if one were to do thrombophilia testing, what is the…
-
Blood or Organ Donation: The Patient on Anticoagulants or with Thrombophillia
-
Protein C Deficiency
Inherited protein C deficiency is considered a stronger thrombophilia. It increases the risk for venous and arterial thromboembolism, and possibly for early and late pregnancy loss and other adverse pregnancy outcomes (preeclampsia, IUGR, placental abruption). There are 2 major causes for low protein C values:
